| Old Articles: <Older 42491-42500 Newer> |
 |
The Motley Fool July 26, 2010 David Lee Smith |
Honeywell Is Verifying the Recovery Despite the economy's continued shakiness, a group of big companies merit watching.  |
The Motley Fool July 26, 2010 Brian Orelli |
Up 20%! Guess That Hedge Wasn't Needed Onyx reports positive data for its recently acquired multiple myeloma drug.  |
The Motley Fool July 26, 2010 Rich Smith |
Will Britannia Rule the Air? BAE Systems flies "out of the sun," catches Boeing and Lockheed napping. the BAE Systems-built Taranis unmanned aerial vehicle is called a "prelude to the next generation of fighting capability."  |
The Motley Fool July 26, 2010 Toby Shute |
Uranium Price Spike Ahead? Surprising signs of life emerge in a normally sleepy time for the yellowcake market.  |
The Motley Fool July 26, 2010 Alex Pape |
5-Minute Breakdown: Timberland Your first step toward becoming an expert on this shoe manufacturer.  |
The Motley Fool July 26, 2010 Christopher Barker |
Potential Kinks in These Haulers' Tracks Recent numbers from railroads corroborate emerging uncertainty about the economy.  |
The Motley Fool July 26, 2010 Alex Pape |
5-Minute Breakdown: McCormick Your first step toward becoming an expert on the spice maker.  |
The Motley Fool July 26, 2010 Brian Orelli |
Beleaguered Biotech for Sale by Owner. Maybe. Will Genzyme's management sell before the turnaround is complete?  |
The Motley Fool July 26, 2010 Russ Krull |
American Capital: Strengths, Weaknesses, Opportunities, Threats This former high-yield company is restructuring for a turnaround.  |
The Motley Fool July 26, 2010 Jim Mueller |
3 Beaten-Down Dividend Payers A look at three companies that might deserve a spot in your portfolio.  |
| <Older 42491-42500 Newer> Return to current articles. |